borderline significancep = 0.059
The EuroScore II was higher in the group with early clinical outcomes (7.3 ± 6.61%) compared to the group without outcomes (4.9 ± 3.55%), with borderline significance ( p = 0.059).
The EuroScore II was higher in the group with early clinical outcomes (7.3 ± 6.61%) compared to the group without outcomes (4.9 ± 3.55%), with borderline significance ( p = 0.059).
Patients with NYHA class III-IV were more likely to experience early clinical outcomes compared to those with NYHA class I-II, but the differences did not reach statistical significance ( p = 0.355).